Aurobindo arm Eugia U.S. recalling antibacterial drug

Aurobindo Pharma subsidiary Eugia US LLC is voluntarily recalling a lot of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (single dose vial) due to presence of particulate matter identified as a glass particle inside the vial.Eugia had shipped the entire lot to wholesalers in the U.S. from September 2-15. It notified the distributors and customers by recall letters and is arranging for return/replacement of all recalled products, the U.S. Food and Drug Administration said on the November 6, 2026, announcement by the company.Vancomycin hydrochloride for injection is a glycopeptide antibacterial indicated in adult and paediatric patients (neonates and older) for the treatment of septicaemia, infective endocarditis, skin and skin structure infections, bone infections and lower respiratory tract infections, the regulator said in a communication on Monday, November 9, 2026. Eugia US LLC was formerly known as Auro Medics Pharma LLC. Published - November 10, 2026 07:30 pm IST